VCM
BLFS icon

Venator Capital Management’s BioLife Solutions BLFS Stock Holding History

Venator Capital Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-403,211
Closed -$7.06M – 34
2018
Q3 		$7.06M Sell
403,211
-66,377
-14% -$1.31M 3.54% 4
2018
Q2 		$5.36M Buy
+469,588
New +$4.27M 3.66% 11

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SCM
Sandler Capital Management New York $193M AUM 77.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
CCM
Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Venator Capital Management's BLFS Position: Q4 2018 in Review

Venator Capital Management sold out of BioLife Solutions (BLFS) in Q4 2018, closing a stake of 403,211 shares — an estimated $7.06M sold.

Venator Capital Management first reported a position in BLFS in Q2 2018 and held it in 2 quarters. The position peaked at $7.06M in Q3 2018. 54 funds tracked by Wall St. Rank hold BLFS as of Q4 2018.

  • Venator Capital Management reported no remaining BioLife Solutions position as of Q4 2018 after selling out during the quarter.
  • Venator Capital Management sold 403,211 BioLife Solutions shares in Q4 2018, an estimated $7.06M.
  • Venator Capital Management first reported a position in BioLife Solutions in Q2 2018 and held it in 2 quarters.
  • Venator Capital Management's BioLife Solutions position peaked at $7.06M in Q3 2018.
  • 54 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2018.

Based on Venator Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.